Skip to content
Medical Health Aged Care

CGFNS Appoints New Chief Technology Officer to Lead its Digital Transformation

CGFNS International 2 mins read

PHILADELPHIA, PA / ACCESSWIRE / September 14, 2023 / Amid technological advances in the credentialing industry and a growing global focus on addressing health workforce deployment, CGFNS International announced today it has appointed a new Chief Technology Officer. Nish Jayamohan comes to CGFNS with nearly two decades of experience managing technology product and application development in the healthcare space.

Nish Jayamohan
Nish Jayamohan
Chief Technology Officer, CGFNS International

As CTO, Jayamohan will lead the organization's efforts to transform its technology platforms and processes with the goal of enhancing and streamlining customer experience, expanding its programs and building a new framework for credentials evaluation and verification and workforce development on a global scale.

"With his record of success in leading large-scale technology implementation projects, Nish is uniquely qualified to head up a digital transformation that will reshape and streamline our applicant user experience and overall customer service," said Peter Preziosi, CGFNS's President and CEO. "As a key innovator in our company leadership, he will be critical to meeting our objective of advancing both mobility and career development for nurses and other health professionals worldwide."

Jayamohan joins CGFNS after serving as Senior Director of Product Management, Software Engineering and Application Development for PharMerica, a national leader in pharmacy services that focuses on senior living communities, nursing facilities, public health organizations and post-acute care organizations. While there, he worked with corporate executive leadership to design and develop technology applications and enhancements to improve the company's customer service and operational processes. He previously served as a senior technical lead developing and managing software for Health Net, a large healthcare insurance provider.

"I am eager to help CGFNS deliver on its obligations to a critically important customer and client base, and particularly to use leading technologies to make its services and programs second to none. Health professionals who dream of migrating to care for patients and advance their careers deserve nothing less," said Jayamohan.

About CGFNS International, Inc.
Founded in 1977 and based in Philadelphia, CGFNS International is an immigration-neutral not-for-profit organization proudly serving as the world's largest credentials evaluation organization for the nursing and allied health professions. CGFNS International is an NGO in Consultative Status with the United Nations Economic and Social Council (ECOSOC) and is a member of the Conference of NGOs in Consultative Relationship with the United Nations (CoNGO). For more information, visit https://www.cgfns.org.

Contact Information

David St. John
[email protected]

SOURCE: CGFNS International

.


View source version on accesswire.com:
https://www.accesswire.com/784310/cgfns-appoints-new-chief-technology-officer-to-lead-its-digital-transformation

More from this category

  • Biotechnology, Medical Health Aged Care
  • 19/03/2026
  • 05:45
La Trobe University

Cell-inspired sensor delivers blood-monitoring breakthrough

A team led by La Trobe University has drawn inspiration from nature to develop a breakthrough sensor that can rapidly track tiny molecular changes…

  • Contains:
  • Medical Health Aged Care
  • 18/03/2026
  • 18:41
Samsung Bioepis Co., Ltd.

Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates

The agreement covers up to five assets, including SB36, a biosimilar candidate referencing Entyvio (vedolizumab), for collaboration of development and commercialization in global markets excluding China, Hong Kong, Taiwan, Macau, and Republic of KoreaSamsung Bioepis continues to pave the way for access to life-changing medicines by advancing a biosimilar pipeline across immunology and oncology   INCHEON, Korea--BUSINESS WIRE-- Samsung Bioepis Co., Ltd. announced today that the company has entered into a global license, development and commercialization agreement (DCA) with Sandoz for up to five biosimilar candidates under development by Samsung Bioepis, including SB36, a biosimilar candidate referencing Entyvio1 (vedolizumab). The…

  • Contains:
  • Medical Health Aged Care
  • 18/03/2026
  • 16:49
Palliative Care Australia

Better end-of-life care for older Australians must be the next step in aged care reform

Palliative Care Australia this week brought leaders from aged care, palliative care, health, advocacy, research and policy together in Melbourne for its inauguralPalliative Care…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.